JP Morgan Chase’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-62,100
Closed -$305K 7706
2023
Q4
$305K Hold
62,100
﹤0.01% 5097
2023
Q3
$338K Sell
62,100
-37,900
-38% -$304K ﹤0.01% 4726
2023
Q2
$926K Sell
100,000
-10,000
-9% -$84.6K ﹤0.01% 4121
2023
Q1
$904K Sell
110,000
-3,100
-3% -$34.2K ﹤0.01% 4119
2022
Q4
$1.26M Sell
113,100
-162,100
-59% -$1.88M ﹤0.01% 3893
2022
Q3
$3.26M Buy
+275,200
New +$4.17M ﹤0.01% 3091

Other funds holding MPT

JP Morgan Chase's MPT Position: Q1 2026 in Review

JP Morgan Chase reduced its Medical Properties Trust (MPT) stake by 16% in Q1 2026, selling an estimated $1.53M and leaving 1,511,657 shares worth $6.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3018.

JP Morgan Chase first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $83.8M in Q4 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • JP Morgan Chase held 1,511,657 shares of Medical Properties Trust worth $6.89M as of Q1 2026.
  • JP Morgan Chase sold 294,244 Medical Properties Trust shares in Q1 2026, an estimated $1.53M.
  • Medical Properties Trust made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3018 holding.
  • JP Morgan Chase first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Medical Properties Trust position peaked at $83.8M in Q4 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.